1. Home
  2. JVA vs LEXX Comparison

JVA vs LEXX Comparison

Compare JVA & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.72

Market Cap

21.0M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$1.08

Market Cap

22.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
LEXX
Founded
1971
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
22.7M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
LEXX
Price
$3.72
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
41.4K
207.6K
Earning Date
09-12-2025
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
$705,923.00
Revenue This Year
N/A
$46.98
Revenue Next Year
N/A
$17.26
P/E Ratio
$11.45
N/A
Revenue Growth
17.92
49.85
52 Week Low
$2.75
$0.77
52 Week High
$9.93
$2.85

Technical Indicators

Market Signals
Indicator
JVA
LEXX
Relative Strength Index (RSI) 42.48 55.22
Support Level $3.32 $1.00
Resistance Level $3.84 $1.15
Average True Range (ATR) 0.25 0.08
MACD 0.01 -0.00
Stochastic Oscillator 45.18 59.50

Price Performance

Historical Comparison
JVA
LEXX

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: